Skip navigation
Speakers

Explore the Impact of Copay Accumulators, Maximizers and Drug Pricing Legislation on Patient Affordability

October 2-4, 2019
  • Philadelphia, PA

Andy Buzbee
VP, Business Development
ConnectiveRx

Stephen Carroll
Pharmacist
AllCare Specialty Pharmacy

Ticia Cawley
VP, Client Solutions
ConnectiveRx

Jim Clement
Partner, Coeus Consulting Group;
former Executive Director, Value-Based Care and Supply Chain Strategy,
Aetna

Bernard Cooney
Assistant United States Attorney
District of New Jersey

Rujul H. Desai
Of Counsel
Covington & Burling LLP

Stefanie Doebler
Of Counsel
Covington & Burling LLP

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Colette Flack
Sr. Director, Access and Patient Services
Dermira, Inc.

Gale Wm. Fraser III
Operations Manager, Specialty Pharmacy Service
Atrium Health

Charlene Fullmer
Deputy Chief for Affirmative Litigation, Civil Division,US Attorney’s Office
District of Eastern Pennsylvania

Douglas Gabbard
President & CEO, Prescriptive Path;
former Director, Savings Offer Strategy, GSK

Mark Hall
Chief Strategy Officer
G8way Health

John Herley
Vice President, Business Development
ConnectiveRx

Anna Hyde
Vice President, Advocacy and Access
The Arthritis Foundation

Liza Khan
Associate
Covington & Burling LLP

Alan Klein
Chief Development Officer
HealthWell Foundation

Robert J. Leinss, Jr., BS Pharm, RPh, MBA
Specialty Pharmacy Consulting Services

Paul LeVine
VP, Corporate Strategy
TrialCard

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

Amy Niles
Vice President, External Relations
Patient Access Network (PAN) Foundation

Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx

Bob Raffo
President & CEO
FirstView

Gerard Rivera, PharmD
CEO
Pacific Pharmacy Group

John Robicsek
Assistant Vice President, Strategy, Business and
Program Development, Pharmacy Administration
Atrium Health

Eric Rubenstein
Fraud and Abuse Consultant, Advize Health LLC;
former Senior Special Agent, U.S. Department of Health and Human Services,
OIG

Carl Schmid
Deputy Executive Director
The AIDS Institute

Brent Schwartz
Executive Director, Marketing and Access
Allergan

Ian Tzeng
Managing Director
L.E.K. Consulting

Randy Vogenberg, Ph.D.
Principal, Institute for Integrated Healthcare (IIH);
Board Chair, Employer Provider Interface Council (EPIC)
of the HQF (Hospital Quality Foundation)

John A. Wylam, Esq.
Staff Attorney
Aimed Alliance

Andy Buzbee
VP, Business Development
ConnectiveRx

Stephen Carroll
Pharmacist
AllCare Specialty Pharmacy

Ticia Cawley
VP, Client Solutions
ConnectiveRx

Jim Clement
Partner, Coeus Consulting Group;
former Executive Director, Value-Based Care and Supply Chain Strategy,
Aetna

Bernard Cooney
Assistant United States Attorney
District of New Jersey

Rujul H. Desai
Of Counsel
Covington & Burling LLP

Stefanie Doebler
Of Counsel
Covington & Burling LLP

Chris Dowd
Executive Vice President, Market and Product Development
ConnectiveRx

Colette Flack
Sr. Director, Access and Patient Services
Dermira, Inc.

Gale Wm. Fraser III
Operations Manager, Specialty Pharmacy Service
Atrium Health

Charlene Fullmer
Deputy Chief for Affirmative Litigation, Civil Division,US Attorney’s Office
District of Eastern Pennsylvania

Douglas Gabbard
President & CEO, Prescriptive Path;
former Director, Savings Offer Strategy, GSK

Mark Hall
Chief Strategy Officer
G8way Health

John Herley
Vice President, Business Development
ConnectiveRx

Anna Hyde
Vice President, Advocacy and Access
The Arthritis Foundation

Liza Khan
Associate
Covington & Burling LLP

Alan Klein
Chief Development Officer
HealthWell Foundation

Robert J. Leinss, Jr., BS Pharm, RPh, MBA
Specialty Pharmacy Consulting Services

Paul LeVine
VP, Corporate Strategy
TrialCard

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

Amy Niles
Vice President, External Relations
Patient Access Network (PAN) Foundation

Kevin O’Meara
Subject Matter Expert, Affordability & Accumulator Strategies
ConnectiveRx

Bob Raffo
President & CEO
FirstView

Gerard Rivera, PharmD
CEO
Pacific Pharmacy Group

John Robicsek
Assistant Vice President, Strategy, Business and
Program Development, Pharmacy Administration
Atrium Health

Eric Rubenstein
Fraud and Abuse Consultant, Advize Health LLC;
former Senior Special Agent, U.S. Department of Health and Human Services,
OIG

Carl Schmid
Deputy Executive Director
The AIDS Institute

Brent Schwartz
Executive Director, Marketing and Access
Allergan

Ian Tzeng
Managing Director
L.E.K. Consulting

Randy Vogenberg, Ph.D.
Principal, Institute for Integrated Healthcare (IIH);
Board Chair, Employer Provider Interface Council (EPIC)
of the HQF (Hospital Quality Foundation)

John A. Wylam, Esq.
Staff Attorney
Aimed Alliance